EIF2A and neoplasm: Western blot analyses and immunohistochemistry of the harvested tumor tissues also revealed that (S)-crizotinib treatment increased the levels of ATF4, CHOP, p-eIF2a (Fig. 5h and i) indicating activation of the ER stress pathway.